机译:伊朗地中海贫血症的分子机制
Maryam Neishabury,1 Azita Azarkeivan,2 Christian Oberkanins,3 Fatemehsadat Esteghamat,1 Naser Amirizadeh,2 and Hossein Najmabadi1,41Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.2Thalassemia Clinic and Research Center, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran.3ViennaLab Diagnostics GmbH, Vienna, Austria.4Kariminejad and Najmabadi Pathology and Genetics Center, Tehran, Iran.Address reprint requests to:Maryam Neishabury, Ph.D.Genetics Research CenterUniversity of Social Welfare and Rehabilitation SciencesEvin, KoodakyarTehran 19834Iran;
Molecular Mechanisms Underlying Thalassemia Intermedia;
机译:伊朗地中海贫血症的分子机制
机译:β地中海贫血的中间分子特征:伊朗的一份报告
机译:β-地中海贫血中间体的分子表征:伊朗的一份报告
机译:了解卵巢癌细胞中顺铂抗性潜在的分子机制
机译:分子印迹聚合物中的分子识别及其潜在机理。
机译:伊朗重型地中海贫血症与中度地中海贫血症的青少年和青年人肾上腺功能不全的频率
机译:青少年肺癌患者中男性和青少年成年人肾上腺功能不全的频率